ARTICLE | Clinical News
FCP-3P1: FMI started trials of its cholesterol lowering agent in Canada.
May 28, 1996 7:00 AM UTC
Forbes Medi-Tech Inc. (VSE:FMI), Vancouver, B.C. Product: FCP-3P1, a composition of phytosterol derived from tall oil Indication: Primary, familial hyperlipidemia Status: FMI started limited trials of...